2023-04-012024-03-312024-03-31false08695571MJM Skin Ltd2024-11-0886220iso4217:GBPxbrli:pure086955712023-04-01086955712024-03-31086955712023-04-012024-03-31086955712022-04-01086955712023-03-31086955712022-04-012023-03-3108695571bus:SmallEntities2023-04-012024-03-3108695571bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3108695571bus:AbridgedAccounts2023-04-012024-03-3108695571bus:PrivateLimitedCompanyLtd2023-04-012024-03-3108695571core:WithinOneYear2024-03-3108695571core:AfterOneYear2024-03-3108695571core:WithinOneYear2023-03-3108695571core:AfterOneYear2023-03-3108695571core:ShareCapital2024-03-3108695571core:SharePremium2024-03-3108695571core:RevaluationReserve2024-03-3108695571core:OtherReservesSubtotal2024-03-3108695571core:RetainedEarningsAccumulatedLosses2024-03-3108695571core:ShareCapital2023-03-3108695571core:SharePremium2023-03-3108695571core:RevaluationReserve2023-03-3108695571core:OtherReservesSubtotal2023-03-3108695571core:RetainedEarningsAccumulatedLosses2023-03-3108695571core:LandBuildings2024-03-3108695571core:PlantMachinery2024-03-3108695571core:Vehicles2024-03-3108695571core:FurnitureFittings2024-03-3108695571core:OfficeEquipment2024-03-3108695571core:NetGoodwill2024-03-3108695571core:IntangibleAssetsOtherThanGoodwill2024-03-3108695571core:ListedExchangeTraded2024-03-3108695571core:UnlistedNon-exchangeTraded2024-03-3108695571core:LandBuildings2023-03-3108695571core:PlantMachinery2023-03-3108695571core:Vehicles2023-03-3108695571core:FurnitureFittings2023-03-3108695571core:OfficeEquipment2023-03-3108695571core:NetGoodwill2023-03-3108695571core:IntangibleAssetsOtherThanGoodwill2023-03-3108695571core:ListedExchangeTraded2023-03-3108695571core:UnlistedNon-exchangeTraded2023-03-3108695571core:LandBuildings2023-04-012024-03-3108695571core:PlantMachinery2023-04-012024-03-3108695571core:Vehicles2023-04-012024-03-3108695571core:FurnitureFittings2023-04-012024-03-3108695571core:OfficeEquipment2023-04-012024-03-3108695571core:NetGoodwill2023-04-012024-03-3108695571core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3108695571core:ListedExchangeTraded2023-04-012024-03-3108695571core:UnlistedNon-exchangeTraded2023-04-012024-03-3108695571core:MoreThanFiveYears2023-04-012024-03-3108695571core:Non-currentFinancialInstruments2024-03-3108695571core:Non-currentFinancialInstruments2023-03-3108695571dpl:CostSales2023-04-012024-03-3108695571dpl:DistributionCosts2023-04-012024-03-3108695571core:LandBuildings2023-04-012024-03-3108695571core:PlantMachinery2023-04-012024-03-3108695571core:Vehicles2023-04-012024-03-3108695571core:FurnitureFittings2023-04-012024-03-3108695571core:OfficeEquipment2023-04-012024-03-3108695571dpl:AdministrativeExpenses2023-04-012024-03-3108695571core:NetGoodwill2023-04-012024-03-3108695571core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3108695571dpl:GroupUndertakings2023-04-012024-03-3108695571dpl:ParticipatingInterests2023-04-012024-03-3108695571dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3108695571core:ListedExchangeTraded2023-04-012024-03-3108695571dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3108695571core:UnlistedNon-exchangeTraded2023-04-012024-03-3108695571dpl:CostSales2022-04-012023-03-3108695571dpl:DistributionCosts2022-04-012023-03-3108695571core:LandBuildings2022-04-012023-03-3108695571core:PlantMachinery2022-04-012023-03-3108695571core:Vehicles2022-04-012023-03-3108695571core:FurnitureFittings2022-04-012023-03-3108695571core:OfficeEquipment2022-04-012023-03-3108695571dpl:AdministrativeExpenses2022-04-012023-03-3108695571core:NetGoodwill2022-04-012023-03-3108695571core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3108695571dpl:GroupUndertakings2022-04-012023-03-3108695571dpl:ParticipatingInterests2022-04-012023-03-3108695571dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3108695571core:ListedExchangeTraded2022-04-012023-03-3108695571dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3108695571core:UnlistedNon-exchangeTraded2022-04-012023-03-3108695571core:NetGoodwill2024-03-3108695571core:IntangibleAssetsOtherThanGoodwill2024-03-3108695571core:LandBuildings2024-03-3108695571core:PlantMachinery2024-03-3108695571core:Vehicles2024-03-3108695571core:FurnitureFittings2024-03-3108695571core:OfficeEquipment2024-03-3108695571core:AfterOneYear2024-03-3108695571core:WithinOneYear2024-03-3108695571core:ListedExchangeTraded2024-03-3108695571core:UnlistedNon-exchangeTraded2024-03-3108695571core:ShareCapital2024-03-3108695571core:SharePremium2024-03-3108695571core:RevaluationReserve2024-03-3108695571core:OtherReservesSubtotal2024-03-3108695571core:RetainedEarningsAccumulatedLosses2024-03-3108695571core:NetGoodwill2023-03-3108695571core:IntangibleAssetsOtherThanGoodwill2023-03-3108695571core:LandBuildings2023-03-3108695571core:PlantMachinery2023-03-3108695571core:Vehicles2023-03-3108695571core:FurnitureFittings2023-03-3108695571core:OfficeEquipment2023-03-3108695571core:AfterOneYear2023-03-3108695571core:WithinOneYear2023-03-3108695571core:ListedExchangeTraded2023-03-3108695571core:UnlistedNon-exchangeTraded2023-03-3108695571core:ShareCapital2023-03-3108695571core:SharePremium2023-03-3108695571core:RevaluationReserve2023-03-3108695571core:OtherReservesSubtotal2023-03-3108695571core:RetainedEarningsAccumulatedLosses2023-03-3108695571core:NetGoodwill2022-04-0108695571core:IntangibleAssetsOtherThanGoodwill2022-04-0108695571core:LandBuildings2022-04-0108695571core:PlantMachinery2022-04-0108695571core:Vehicles2022-04-0108695571core:FurnitureFittings2022-04-0108695571core:OfficeEquipment2022-04-0108695571core:AfterOneYear2022-04-0108695571core:WithinOneYear2022-04-0108695571core:ListedExchangeTraded2022-04-0108695571core:UnlistedNon-exchangeTraded2022-04-0108695571core:ShareCapital2022-04-0108695571core:SharePremium2022-04-0108695571core:RevaluationReserve2022-04-0108695571core:OtherReservesSubtotal2022-04-0108695571core:RetainedEarningsAccumulatedLosses2022-04-0108695571core:AfterOneYear2023-04-012024-03-3108695571core:WithinOneYear2023-04-012024-03-3108695571core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3108695571core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3108695571core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3108695571core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3108695571core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3108695571core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3108695571core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3108695571core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3108695571core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3108695571core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3108695571core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3108695571core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3108695571core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3108695571core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3108695571core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3108695571core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3108695571core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3108695571core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3108695571core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3108695571core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3108695571core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3108695571core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3108695571core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3108695571core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3108695571core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3108695571core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3108695571core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3108695571bus:Director12023-04-012024-03-3108695571bus:Director22023-04-012024-03-31

MJM Skin Ltd

Registered Number
08695571
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

MJM Skin Ltd
Company Information
for the year from 1 April 2023 to 31 March 2024

Directors

Mohungoo, Muhammad Javed, Dr
Sorefan, Nesha Bibi, Dr

Company Secretary

Sorefan, Nesha, Dr

Registered Address

33 Tranby Lane
Swanland
North Ferriby
HU14 3NE

Registered Number

08695571 (England and Wales)
MJM Skin Ltd
Balance Sheet as at
31 March 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets3145,57187,524
Investments41010
145,58187,534
Current assets
Debtors217,732143,957
Cash at bank and on hand171,161548,125
388,893692,082
Creditors amounts falling due within one year(98,405)(54,791)
Net current assets (liabilities)290,488637,291
Total assets less current liabilities436,069724,825
Creditors amounts falling due after one year(93,522)(62,971)
Net assets342,547661,854
Capital and reserves
Called up share capital1010
Profit and loss account342,537661,844
Shareholders' funds342,547661,854
The financial statements were approved and authorised for issue by the Board of Directors on 8 November 2024, and are signed on its behalf by:
Mohungoo, Muhammad Javed, Dr
Director
Registered Company No. 08695571
MJM Skin Ltd
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
2.Average number of employees

20242023
Average number of employees during the year11
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 April 23118,459
Additions79,573
At 31 March 24198,032
Depreciation and impairment
At 01 April 2330,935
Charge for year21,526
At 31 March 2452,461
Net book value
At 31 March 24145,571
At 31 March 2387,524
4.Fixed asset investments

Total

£
Cost or valuation
At 01 April 2310
At 31 March 2410
Net book value
At 31 March 2410
At 31 March 2310
5.Obligations under finance leases

2024

2023

££
Finance lease and HP contracts93,52262,971
6.Related party transactions
The company holds 100% of the share capital of MJM Brigg Limited (company number 083304296). The amounts owing to the parent company at the balance sheet date was £100,752 (£100,343 - 2021).